Drug Profile
Research programme: antibacterials - Deinove
Alternative Names: Bacterial topoisomerase I inhibitors - Deinove; Enzyme inhibitors - Deinove; MCB 1033; MCB 116; MCB-4657; MCB-4658; MCTI programme - Deinove; Topoisomerase inhibitors - Deinove; Topoisomerase IV inhibitors - DeinoveLatest Information Update: 07 Feb 2019
Price :
$50
*
At a glance
- Originator Morphochem AG
- Class Antibacterials; Oxazolidinones; Small molecules
- Mechanism of Action DNA topoisomerase inhibitors; Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Bacterial infections
Most Recent Events
- 15 Dec 2006 Suspended - Preclinical for Bacterial infections in Switzerland (unspecified route)
- 15 Dec 2006 Suspended - Preclinical for Bacterial infections in USA (unspecified route)
- 17 Oct 2006 Data presented at the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2006) have been added to the Bacterial Infections pharmacodynamics section